Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > This Mysterious Bit of Information We Await
View:
Post by skys1 on Aug 11, 2021 2:34pm

This Mysterious Bit of Information We Await

All I can say is whatever this one bit of information they are waiting for to realease the "Quarterly"  must be extremely important or they will look very foolish. At this point in time, the "Quarterly" is no longer a quarterly. If in fact it was, it would have been out about first week of July. It can no longer be called a Quarterly Newsletter.
Comment by Oilminerdeluxe on Aug 11, 2021 3:47pm
Perhaps a better name would be "quartered..." That's what it fels like being a TLT shareholder,. Well, here's to hoping for a nice update whenever it arrives. But no Friday one, please.
Comment by consultant99 on Aug 12, 2021 11:58am
While patiently waiting for a crumb of useful information I can honestly say that the treatment investors get is a joke.  If not for the blinding potential of their product I would have been long gone. I sincerely hope that the indifference being shown is not due to another hiccup because it seems whenever they have been silent it has been because of an unexpected problem. Hopefully this ...more  
Comment by tamarindo1 on Aug 12, 2021 2:36pm
Well I guess it's SFA for this week.
Comment by tamarindo1 on Aug 12, 2021 2:40pm
Don't you just love the sound of silence! https://youtu.be/Bk7RVw3I8eg
Comment by Pandora on Aug 12, 2021 5:40pm
I wouldn't mind so much if it was just this one company but I have at least 6 others that are in the same silence mode. It's almost as if the small cap tech market was all given an instruction to keep their shareholders completely in the dark through the summer - maybe longer. At least miner's keep drilling holes and mapping hot spots so they keep yakking but I only have one of those.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250